ArticleBMC infectious diseases2025
Long-term symptoms after SARS-CoV-2 infection in a cohort of healthcare workers in Qatar.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDuring the Coronavirus Disease 2019 pandemic, healthcare workers faced a significantly elevated risk of exposure and infection compared to the general population due to their frontline roles in patient care. This heightened risk was compounded by the nature of their work environment and prolonged contact with infected individuals. Despite extensive research on the virus’s immediate impact, limited data exists regarding the prevalence of long-term symptoms, commonly referred to as Long COVID, among healthcare workers. In this study, we aimed to investigate the prevalence and profile of long-term symptoms following SARS-CoV-2 infection, along with associated risk factors, among healthcare workers, with a particular focus on regional data from the Middle East, and to contextualize these findings within the global evidence base.
methodsThis cross-sectional, web-based survey was conducted among healthcare workers at Hamad Medical Corporation, the largest healthcare provider in Qatar, between 24 January 2022 and 24 April 2022. Healthcare workers aged 18 years or older, including physicians, nurses, allied healthcare professionals, and administrative staff, were eligible to participate. The survey assessed the prevalence of Long COVID-19 symptoms, and the symptoms of depression, and anxiety. Over a four-week data collection period, we received 783 complete responses, which exceeded the minimum required sample size.
resultsOf the respondents, three-quarters reported long-term symptoms after SARS-CoV-2 infection, and one-third reported more than three symptoms. Fatigue was the most common symptom. Gender disparities were observed, with females experiencing a higher incidence of symptoms. Significant associations were identified between a history of SARS-CoV-2 infection, a psychiatric history, symptoms of depression, and the development of multiple Long COVID-19 symptoms.
conclusionThese findings highlight the significant burden of Long COVID-19 symptoms on healthcare workers well-being in Qatar. The study underscores the need for targeted interventions to support them, especially those at greater risk of adverse outcomes. From a healthcare system perspective, addressing Long COVID-19 symptoms among healthcare workers is critical to maintaining a resilient workforce. This includes implementing access to mental health resources, structured follow-up, and workplace accommodation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.